Priapismus
详细信息 查看全文
- 作者：PD Dr. Dr. T. Bschleipfer F.E.B.U ; Dr. B. Schwindl ; T. Klotz
- 关键词：鈥濴ow ; flow鈥?Priapismus ; Isch盲mischer Priapismus ; 鈥濰igh ; flow鈥?Priapismus ; Rezidivierender Priapismus ; 鈥濻tuttering鈥?Priapismus ; Low ; flow priapism ; Ischemic priapism ; High ; flow priapism ; Recurrent priapism ; Stuttering priapism
- 刊名：Der Urologe A
- 出版年：2015
- 出版时间：November 2015
- 年：2015
- 卷：54
- 期：11
- 页码：1631-1641
- 全文大小：620 KB
- 参考文献：1.Eland IA, Lei J van der, Stricker BH et al (2001) Incidence of priapism in the general population. Urology 57:970鈥?72PubMed CrossRef
2.Dust N, Daboval T, Guerra L (2011) Evaluation and management of priapism in a newborn: a case report and review of the literature. Paediatr Child Health 16:e6鈥揺8PubMed PubMedCentral
3.Cruz N (2012) Priapism. In: Porst H, Reisman Y (Hrsg) The ESSM syllabus of sexual medicine. Medix, Amsterdam, S 664鈥?79
4.Kirkham AP, Illing RO, Minhas S et al (2008) MR imaging of nonmalignant penile lesions. Radiographics 28:837鈥?53PubMed CrossRef
5.Montague DK, Jarow J, Broderick GA et al (2003) American Urological Association guideline on the management of priapism. J Urol 170:1318鈥?324PubMed CrossRef
6.Salonia A, Eardley I, Giuliano F et al (2014) European Association of Urology guidelines on priapism. Eur Urol 65:480鈥?89PubMed CrossRef
7.McDonald M, Santucci RA (2004) Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol. Int Braz J Urol 30:121鈥?22PubMed CrossRef
8.Gbadoe AD, Atakouma Y, Kusiaku K et al (2001) Management of sickle cell priapism with etilefrine. Arch Dis Child 85:52鈥?3PubMed PubMedCentral CrossRef
9.Martinez Portillo F, Hoang-Boehm J, Weiss J et al (2001) Methylene blue as a successful treatment alternative for pharmacologically induced priapism. Eur Urol 39:20鈥?3
10.Bennett N, Mulhall J (2008) Sickle cell disease status and outcomes of African-American men presenting with priapism. J Sex Med 5:1244鈥?250PubMed CrossRef
11.Broderick GA (2012) Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy. J Sex Med 9:88鈥?03PubMed CrossRef
12.Ebbehoj J (1974) A new operation for priapism. Scand J Plast Reconstr Surg 8:241鈥?42PubMed CrossRef
13.Winter CC (1976) Cure of idiopathic priapism: new procedure for creating fistula between glans penis and corpora cavernosa. Urology 8:389鈥?91PubMed CrossRef
14.Quackels R (1964) Treatment of a case of priapism by cavernospongious anastomosis. Acta Urol Belg 32:5鈥?3PubMed
15.Grayhack JT, McCullough W, O鈥機onor VJ Jr et al (1964) Venous bypass to control priapism. Invest Urol 1:509鈥?13PubMed
16.Eiland LS, Bell EA, Erramouspe J (2014) Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children. Ann Pharmacother 48:1350鈥?355PubMed CrossRef
17.M眉ller-Oerlinghausen B, Ringel I (2002) Medikamente als Verursacher sexueller Dysfunktionen: Eine Analyse von Daten des deutschen Spontanerfassungssystems. Dtsch Arztebl 99:A-3108
18.Ahmed I, Shaikh NA (1997) Treatment of intermittent idiopathic priapism with oral terbutaline. Br J Urol 80:341PubMed CrossRef
19.Levine LA, Guss SP (1993) Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism. J Urol 150:475鈥?77PubMed
20.Bialecki ES, Bridges KR (2002) Sildenafil relieves priapism in patients with sickle cell disease. Am J Med 113:252PubMed CrossRef
21.Burnett AL, Bivalacqua TJ, Champion HC et al (2006) Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology 67:1043鈥?048PubMed CrossRef
22.Levey HR, Kutlu O, Bivalacqua TJ (2012) Medical management of ischemic stuttering priapism: a contemporary review of the literature. Asian J Androl 14:156鈥?63PubMed PubMedCentral CrossRef
23.Pierorazio PM, Bivalacqua TJ, Burnett AL (2011) Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation. J Androl 32:371鈥?74PubMed CrossRef
24.Tzortzis V, Mitrakas L, Gravas S et al (2009) Oral phosphodiesterase type 5 inhibitors alleviate recurrent priapism complicating thalassemia intermedia: a case report. J Sex Med 6:2068鈥?071PubMed CrossRef
25.Burnett AL, Sharlip ID (2013) Standard operating procedures for priapism. J Sex Med 10:180鈥?94PubMed CrossRef - 作者单位：PD Dr. Dr. T. Bschleipfer F.E.B.U (1)
Dr. B. Schwindl (1)
T. Klotz (1)
1. Klinik f眉r Urologie, Andrologie und Kinderurologie, Klinikum Weiden/Kliniken Nordoberpfalz AG, S枚llnerstr. 16, 92637, Weiden, Deutschland - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Urology and Andrology - 出版者：Springer Berlin / Heidelberg
- ISSN：1433-0563
文摘
Priapism is characterized by involuntary persistent penile erection after or independent of sexual stimulation. The diagnostic clarification, including patient history, physical findings, duplex ultrasonography and analysis of blood gases is decisive for the underlying pathophysiology and the appropriate therapeutic procedure. Non-hypoxic and non-acidotic blood gas parameters enable a conservative approach, hypoxic, hypercarbic and acidotic parameters may lead to fibrosis of the corpora cavernosa and, in turn, to a loss of penile function. Low-flow or ischemic (veno-occlusive) priapism is an emergency situation and can lead to irreversible erectile dysfunction within 4 h. Treatment consists of blood aspiration and possibly intracavernosal injection of sympathomimetic drugs. A distal shunt is necessary in the case of treatment failure (in rare cases a proximal shunt). Management of recurrent priapism (stuttering) includes self-injection of sympathomimetic drugs and preventive long-term administration of erection inhibitory and erection promoting substances. This concept still needs to be validated. High-flow or non-ischemic priapism does not necessitate immediate treatment measures and should be kept under observation. In cases of a detectable fistula selective artery embolization is often a successful option. Keywords Low-flow priapism Ischemic priapism High-flow priapism Recurrent priapism Stuttering priapism